{"brief_title": "Lofexidine for Opiate Withdrawal - 1", "brief_summary": "The purpose of this study is to evaluate lofexidine for opiate withdrawal.", "detailed_description": "An 11 day inpatient placebo-controlled, double-blind study of 96 opiate dependent, treatment seeking individuals randomized to 2 medication groups: lofexidine and placebo to be conducted in inpatient units at 3 treatment sites.", "condition": ["Opioid-Related Disorders"], "intervention_type": ["Drug"], "intervention_name": ["Lofexidine"], "criteria": "Inclusion Criteria: Male or female as least 18 yrs of age & above with a current dependence on heroin, morphine or hydromorphone according to DSM4 criteria; subject ; voluntarily given consent and signed informed consent; females using appropriate birth control method. Exclusion Criteria: Additional criteria available during screening at the site", "gender": "All", "minimum_age": "18 Years", "maximum_age": "99 Years", "healthy_volunteers": "No", "keyword": "opiate dependence", "mesh_term": ["Opioid-Related Disorders", "Lofexidine", "Clonidine"], "id": "NCT00032942"}